Jennifer Martynowicz Selected Research

Guanabenz (BR 750)

1/2021	Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis.
1/2020	Efficacy of Guanabenz Combination Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains.
1/2019	Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer Martynowicz Research Topics

Disease

4	Cysts 01/2021 - 01/2019
3	Toxoplasmosis 01/2021 - 01/2019
2	Infections 01/2020 - 01/2020
1	Inflammation (Inflammations) 01/2019
1	Neuroinflammatory Diseases 01/2019

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
3	Guanabenz (BR 750)FDA Link 01/2021 - 01/2019
2	Pyrimethamine (Daraprim)FDA Link 01/2021 - 01/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2020
1	QuinolonesIBA 01/2020
1	FilaminsIBA 01/2020
1	Antiparasitic Agents (Antiparasitics)IBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020